2018
DOI: 10.1371/journal.pntd.0006366
|View full text |Cite
|
Sign up to set email alerts
|

Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)—Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests

Abstract: As the most widespread tick-borne arbovirus causing infections in numerous countries in Asia, Africa and Europe, Crimean-Congo Hemorrhagic Fever Virus (CCHFV, family Nairoviridae) was included in the WHO priority list of emerging pathogens needing urgent Research & Development attention. To ensure preparedness for potential future outbreak scenarios, reliable diagnostic tools for identification of acute cases as well as for performance of seroprevalence studies are necessary. Here, the CCHFV ortholog of the ma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
44
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(47 citation statements)
references
References 55 publications
(80 reference statements)
3
44
0
Order By: Relevance
“…These methods were replaced by ELISA and immunofluorescence assays due to improved reliability and sensitivity compared with older techniques (10,68,69). Many in-house ELISAs have been described utilizing either heat-inactivated CCHFV prepared from suckling mouse brain or, more commonly, recombinant CCHFV nucleocapsid protein as the target antigen (10,41,(70)(71)(72)(73)(74)(75)(76)(77)(78). Several commercial ELISA kits are available for research use, but none are approved for human clinical diagnostic testing.…”
Section: Cchf Serological Testingmentioning
confidence: 99%
“…These methods were replaced by ELISA and immunofluorescence assays due to improved reliability and sensitivity compared with older techniques (10,68,69). Many in-house ELISAs have been described utilizing either heat-inactivated CCHFV prepared from suckling mouse brain or, more commonly, recombinant CCHFV nucleocapsid protein as the target antigen (10,41,(70)(71)(72)(73)(74)(75)(76)(77)(78). Several commercial ELISA kits are available for research use, but none are approved for human clinical diagnostic testing.…”
Section: Cchf Serological Testingmentioning
confidence: 99%
“…As a part of most advanced immunotechniques, an ultrasensitive colorimetric assay called magnetic nano(e)zyme-linked immunosorbent assay (MagLISA) was developed, wherein silica-shelled magnetic nanobeads (MagNBs) and gold nanoparticles were pooled to monitor influenza A virus up to femtogram per milliliter concentration (Oh et al 2018). Sensitive and specific detection of Crimean-Congo hemorrhagic fever virus (CCHFV) was developed employing specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests (Emmerich et al 2018). Recently, truncated forms of HeV and NiV (Hendra and Nipah virus) G proteins as well as full-length NiV nucleocapsid (N) protein were used for detection of Hendra and Nipah virus specific antibodies in pigs.…”
Section: Elisa-based Immunodetectionmentioning
confidence: 99%
“…Ellipticity values (mdeg) were normalized to mean molar ellipticity per residue (MRE). Thermal data was analysed using Global3 (Applied Photophysics), and secondary structure content predicted using BeStSel [14].…”
Section: Circular Dichroismmentioning
confidence: 99%
“…RT-PCR methods are the current gold standard for detection of CCHFV during the viremic phase, offering sensitive and highly specific results [12]. An antigen-detection ELISA test (VectoCrimea-CHF-antigen, VectorBest) is commercially available, but most available immunoassays are based on detection of CCHFV-specific IgG or IgM [13][14][15][16][17]. Such tests are normally used in animal serosurveys [16,18] or during late phases of disease but, in severe patients cases, the production of antibodies is normally delayed, low, or even absent [19].…”
Section: Introductionmentioning
confidence: 99%